Ypsomed verkauft das Diabetesgeschäft und wächst mit über 35%
» Report
Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.
Anmelden oder
Jetzt abonnieren!
Archiv: Unternehmen
Ypsomed sells its diabetes business and grows by over 35%
» Report
SoftwareONE Holding AG: SoftwareOne reports margin improvement despite revenue decline in Q1 2025
» Report
SoftwareONE Holding AG: SoftwareOne verzeichnet Margenverbesserung trotz Umsatzrückgang im ersten Quartal 2025
» Report
Kuehne+Nagel Group: Evonik selects Kuehne+Nagel to lead logistics excellence in Asia-Pacific
» Report
Avolta prices EUR 500 million of senior notes
» Report
The Adecco Group and the European Automobile Manufacturers' Association (ACEA) Join Forces to Tackle Automotive Skill Transformation
» Report
Logitech - Logitech Announces Proposed Fiscal Year 2025 Dividend
» Report
Roche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
» Report
Julius Baer Group Ltd.: Interim Management Statement for the first four months of 2025*
» Report
WISeKey International Holding Ltd Announces Agenda Items to be Approved by Shareholders at its 2025 Annual General Meeting Scheduled for June 19, 2025
» Report
Cutting maintenance costs by 60%: Burckhardt Compression’s innovative solutions for PTT Global Chemical
» Report
DocMorris AG: Pelion invests in DocMorris
» Report
DocMorris AG: Pelion beteiligt sich an DocMorris
» Report
Logitech - Logitech G’s Streamlabs Unveils Breakthrough AI Streaming Agent Features at Computex with NVIDIA and Inworld AI
» Report
Temenos launches Gen AI Copilot for banks to deliver better products faster
» Report
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
» Report
Basilea gibt Verkaufsstart seines Antibiotikums Zevtera® (Ceftobiprol) in den USA bekannt
» Report
DKSH Management AG: DKSH Performance Materials Acquires Specialty Polymers Distributor APN Plastics in Australia and Malaysia
» Report
Swiss Life Holding AG: Swiss Life continues on its growth path in the first quarter of 2025
» Report
